Age‐ and Sex‐Related Trends in Psychotropic Prescribing Among Youths in Denmark and the United States : 2010–2020
Pharmacoepidemiology and Drug Safety · 2025
DOI: 10.1002/pds.70256 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Pharmacoepidemiology and Drug Safety, 2025. Verfasst von Phuong Tran und 5 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, University of Maryland, Baltimore, Maryland, USA. Hauptthemen laut MEDLINE: Practice Patterns, Physicians', Psychotropic Drugs, Drug Prescriptions. Die Arbeit nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Objectives
To compare age‐ and sex‐specific trends of psychotropic prescribing between Danish and US 3–17‐year‐old youths.
Methods
A consecutive annual cross‐sectional study of trends in psychotropic prescribing from 2010 to 2020. Data sources included the Danish National Prescription Registry data and, for the US, a 25% random sample of the IQVIA PharMetrics Plus for Academics database. Psychotropic prescribing (i.e., ADHD medications, antidepressants, and antipsychotics), measured as annual prevalence, was estimated for each therapeutic class, by age group and sex, separately by country. We used Joinpoint models to calculate the average annual percentage change (AAPC).
Results
ADHD medication prescribing decreased for 5–9 year‐olds in both countries from 2010 to 2020, while prescribing among 10–17 year‐olds was stable in the US and increased in Denmark, particularly among females (AAPC = 4.2% versus 1.4% among males). Antidepressant prescribing increased in older US youths, especially among 14–17 year‐olds (AAPC = 6.5%), and females (AAPC = 7.2%). In Denmark, however, prescribing was low and decreased over time, especially among females (AAPC = −4.2%). Antipsychotic prescribing decreased in both countries for all age groups, with the largest decrease among males (Denmark: AAPC = −5.2% and US: AAPC = −6.1%).
Conclusion
Pediatric antipsychotic prescribing generally decreased, whereas ADHD medication and antidepressant prescribing presented opposing patterns in the two countries. ADHD medication prescribing increased among Danish females and adolescents, but was stable in the US. Antidepressant prescribing decreased in Denmark, particularly among females, which opposed the marked rise for this group in the US. Future cross‐national studies should examine the rationale underpinning variation in antidepressant prescribing.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Pharmacy, University of Maryland, Baltimore, Maryland, USA.
- Clinical Pharmacology, Pharmacy and Environmental Medicine, Department of Public Health, University of Southern Denmark, Odense, Denmark.
- OPEN Research Unit, Department of Clinical Research, University of Southern Denmark, Odense, Denmark.
- Child and Adolescent Psychiatry Southern Denmark, Mental Health Services in the Region of Southern Denmark, Odense, Denmark.
- Centre for Pharmacoepidemiology, Department of Medicine, Karolinska Institutet, Stockholm, Sweden.
ORCID-Profile: Phuong Tran, Lotte Rasmussen, Susan dosReis
Zitieren
APA
Tran, P., Rasmussen, L., Amill-Rosario, A., Bliddal, M., dosReis, S., & Wesselhoeft, R. (2025). Age‐ and Sex‐Related Trends in Psychotropic Prescribing Among Youths in Denmark and the United States : 2010–2020. Pharmacoepidemiology and Drug Safety. https://doi.org/10.1002/pds.70256
Vancouver
Tran P, Rasmussen L, Amill-Rosario A, Bliddal M, dosReis S, Wesselhoeft R. Age‐ and Sex‐Related Trends in Psychotropic Prescribing Among Youths in Denmark and the United States : 2010–2020. Pharmacoepidemiology and Drug Safety. 2025. doi:10.1002/pds.70256
BibTeX
@article{Tran2025,
author = {Tran, Phuong and Rasmussen, Lotte and Amill-Rosario, Alejandro and Bliddal, Mette and dosReis, Susan and Wesselhoeft, Rikke},
title = {Age‐ and Sex‐Related Trends in Psychotropic Prescribing Among Youths in Denmark and the United States : 2010–2020},
journal = {Pharmacoepidemiology and Drug Safety},
year = {2025},
doi = {10.1002/pds.70256}
}
EUVIMED